Literature DB >> 19434770

Is multiple sclerosis a generalized disease of the central nervous system? An MRI perspective.

Declan Chard1, David Miller.   

Abstract

PURPOSE OF REVIEW: Is multiple sclerosis (MS) a generalized disease of the central nervous system? Or put another way, is MS pathology primarily focal with global consequences or global with focal consequences? Consideration of this question depends on how you view it both spatially and temporally. In this review, we address some of the main themes underlying this issue, drawing on evidence especially from MRI, but also from histopathological studies. RECENT
FINDINGS: Pathology in MS is not confined only to white matter lesions; apparently normal appearing tissues, including the grey matter, are also affected. Within what is classified as normal-appearing tissue, there may be variable degrees of demyelination, particularly in the grey matter, along with regions that will eventually become overtly lesion containing and areas of remyelination. It remains uncertain whether changes within the normal-appearing tissues are immediately associated with, or a direct consequence of, lesion formation.
SUMMARY: At present, it is not possible to determine whether lesion formation, or a more diffuse process, is the principal pathological event in MS.

Entities:  

Mesh:

Year:  2009        PMID: 19434770     DOI: 10.1097/wco.0b013e32832b4c62

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  8 in total

1.  Adult stem cells and multiple sclerosis.

Authors:  N Scolding
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

2.  Multi-modal quantitative MRI investigation of brain tissue neurodegeneration in multiple sclerosis.

Authors:  Khader M Hasan; Indika S Walimuni; Humaira Abid; Jerry S Wolinsky; Ponnada A Narayana
Journal:  J Magn Reson Imaging       Date:  2012-01-12       Impact factor: 4.813

3.  Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: implications for understanding the pathogenesis of multiple sclerosis and consolidation of quantitative MRI results in MS.

Authors:  Khader M Hasan; Indika S Walimuni; Humaira Abid; Sushmita Datta; Jerry S Wolinsky; Ponnada A Narayana
Journal:  J Neurol Sci       Date:  2011-10-05       Impact factor: 3.181

4.  Multimodal quantitative magnetic resonance imaging of thalamic development and aging across the human lifespan: implications to neurodegeneration in multiple sclerosis.

Authors:  Khader M Hasan; Indika S Walimuni; Humaira Abid; Richard E Frye; Linda Ewing-Cobbs; Jerry S Wolinsky; Ponnada A Narayana
Journal:  J Neurosci       Date:  2011-11-16       Impact factor: 6.167

5.  Effects of gadolinium contrast agent administration on automatic brain tissue classification of patients with multiple sclerosis.

Authors:  J B M Warntjes; A Tisell; A-M Landtblom; P Lundberg
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-03       Impact factor: 3.825

6.  Axonal damage in the making: neurofilament phosphorylation, proton mobility and magnetisation transfer in multiple sclerosis normal appearing white matter.

Authors:  A Petzold; D J Tozer; K Schmierer
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

7.  A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology.

Authors:  James Kolasinski; Charlotte J Stagg; Steven A Chance; Gabriele C Deluca; Margaret M Esiri; Eun-Hyuk Chang; Jacqueline A Palace; Jennifer A McNab; Mark Jenkinson; Karla L Miller; Heidi Johansen-Berg
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

8.  Brain characterization using normalized quantitative magnetic resonance imaging.

Authors:  Jan B M Warntjes; Maria Engström; Anders Tisell; Peter Lundberg
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.